Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 425-430

  Wang, Bin ^a   Pan, Jinshun ^a   Wang, Liansheng ^a   Zhu, Huaijun ^a   Yu, Rongbin ^a   Zou, Ying ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

8 Isoprostane; Angiography; Atherosclerosis; Coronary artery disease; Oxidative stress

Indexed keywords

8 ISOPROSTANE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHINA; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DINOPROST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; OXIDATIVE STRESS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 30044434546     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.05.008     Document Type: Article

References (29)

1. W. Marz, H. Scharnagl, and K. Winkler Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen risk and cardiovascular health study Circulation 110 2004 3068 3074
2. H. Taniguchi, Y. Momiyama, and R. Ohmori Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease Atherosclerosis 178 2005 173 177
3. S. Ramachandruni, E. Handberg, and D.S. Sheps Acute and chronic psychological stress in coronary disease Curr Opin Cardiol 19 2004 494 499
4. D.J. Hyman, and V.N. Pavlik Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention Curr Atheroscler Rep 5 2003 131 138
5. Z. Yang, J. Zhang, and R. Zhang Relationship of cardiac troponin I to the late heart events in patients with coronary heart disease Chin J Cardiol 30 2002 149 151 [in Chinese]
6. Z. Chen, J. Huang, and T. Zhu Relationship between carotid artery intima media thickness and apolipoprotein E genotypes among patients with premature coronary heart disease Chin J Arterioscler 10 2002 434 436 [in Chinese]
7. W. Qian, Q. Wang, and T. Zhu Initial study on the association of lipoprotein lipase gene polymorphisms with coronary heart disease Chin J Cardiol 26 1998 309 312 [in Chinese]
8. R. Zhang, Z. Yang, F. Zhang, T. Zhu, L. Wang, and J. Huang Relationship of C-reactive protein to the late heart events in patients with coronary heart disease Acta Univ Med Nanjing 23 2003 284 285 [in Chinese]
9. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and L.J. Roberts A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci U S A 87 1990 9383 9387
10. J.D. Morrow, and L.J. Roberts The isoprostanes: unique bioactive products of lipid peroxidation Prog Lipid Res 36 1997 1 21
11. D. Pratico, J.A. Lawson, J. Rokach, and G.A. FitzGerald The isoprostanes in biology and medicine Trends Endocrinol Metab 12 2001 243 247
12. A. Mezzetti, F. Cipollone, and F. Cuccurullo Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm Cardiovasc Res 47 2000 475 488
13. P.S. Lim, Y.M. Chang, and L.M. Thien 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients Blood Purif 20 2002 537 542
14. P. Montuschi, P.J. Barnes, and L.J. Roberts Isoprostanes: markers and mediators of oxidative stress FASEB J 18 2004 1791 1800
15. T. Mueller, B. Dieplinger, and A. Gegenhuber Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease J Vasc Surg 40 2004 768 773
16. S. Kinlay, D. Behrendt, and J.C. Fang Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function J Am Coll Cardiol 43 2004 629 634
17. C. Vassalle, L. Petrozzi, N. Botto, M.G. Andreassi, and G.C. Zucchelli Oxidative stress and its association with coronary artery disease and different atherogenic risk factors J Intern Med 256 2004 308 315
18. S. Clejan, S. Japa, C. Clemetson, S.S. Hasabnis, O. David, and J.V. Talano Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis J Cell Mol Med 6 2002 583 592
19. E. Schwedhelm, A. Bartling, and H. Lenzen Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study Circulation 109 2004 843 848
20. S.H. Wilson, P.J. Best, L.O. Lerman, D.R. Holmes, D.M. Richardson, and A. Lerman Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2alpha, in experimental hypercholesterolemia Cardiovasc Res 44 1999 601 607
21. P. Minuz, P. Patrignani, and S. Gaino Determinants of platelet activation in human essential hypertension Hypertension 43 2004 64 70
22. S.M. Miggin, and B.T. Kinsella Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells Biochim Biophys Acta 1539 2001 147 162
23. L.J. Roberts, and J.P. Fessel The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation Chem Phys Lipids 128 2004 173 186
24. A. Oguogho, and H. Sinzinger Isoprostanes in atherosclerosis J Physiol Pharmacol 51 2000 673 682
25. M. Gross, M. Steffes, and D.R. Jacobs Jr. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA study Clin Chem 51 2005 125 131
26. C. Vassalle, N. Botto, M.G. Andreassi, S. Berti, and A. Biagini Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease Coron Artery Dis 14 2003 213 218
27. E. Arosio, C.L. Santonastaso, A. Lechi, and C. Patrono Determinants of platelet activation in human essential hypertension Hypertension 43 2004 64 70
28. F. Violi, L. Loffredo, L. Musella, and A. Marcoccia Should antioxidant status be considered in interventional trials with antioxidants? Heart 90 2004 598 602
29. H. Shen, Y. Xu, and Y. Zheng Polymorphisms of 5,10- methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study Int J Cancer 95 2001 332 336